Global Fund prepares new to plan to subsidize malaria treatment cost
View on TropIKA.net website
Ramanan Laxminarayan is identified as participating in the Roll Back Malaria (RBM) AMFm Taskforce and notes that the purpose of the project is to undercut the monotherapies market.